Conference

Agenda

DAY 1

FINAL AGENDA

DAY 1
CANCER POLICY IN THE COVID-19 ERA

09.15 – 09.30 OPENING REMARKS
Conference Moderator: Nelly Kapsi, Editor in Chief, Health Daily
Thanos Plevris, Minister of Health, Ministry of Health Greece
Michalis Hadjipandelas, Minister of Health, Ministry of Health Cyprus
Stella Kyriakides, Commissioner, Health and Food Safety

09.30 – 11:30

SESSION 1 | MAKING CANCER FIGHT A POLICY PRIORITY

Moderator: Nelly Kapsi, Editor in Chief, Health Daily

Keynote Speeches

Amanda Psyrri, ESMO Nomination Committee Chair, Associate Professor of Medical Oncology, National Kapodistrian University of Athens, Medical School, Chief of Oncology, Attikon University Hospital
Elena Kountoura, Member of the European Parliament, President, Europa Donna Hellas

Panelists

Εvangelos Filopoulos, President, Hellenic Cancer Society, Surgeon, Director of the Breast Cancer Clinic “Agios Savvas”
Maria Ioannidou, Executive Director of the Cyprus Anti-Cancer Society
Kathi Apostolidis, President, ELLOK, Board Member, ECPC European Cancer Patient Coalition
11:30 – 12:30 Expo – Networking Break

12:30 – 14:15

SESSION 2 | CANCER DRUG DEVELOPMENT: HOW CAN PUBLIC ORGANIZATIONS, ACADEMIA AND INDUSTRY WORK TOGETHER

Moderator: Nikolaos Tsoukalas, MD, MSc, PhD, Medical Oncologist, MSc Bioinformatics, Deputy Director, Oncology Department, 401 General Military Hospital, Consultant, ‘Henry Dunant’ Hospital Center, Athens Greece, Vice President Hellenic Society of Medical Oncology (Hesmo)
Dimitris Philippou, MD, Phd. President, National Organization for Medicines (EOF), Assistant Professor of Anatomy and Surgical Anatomy at the Medical School of the National Kapodistrian University of Athens, President of the Medicines Negotiations Committee and Executive Member of KESY
Assessing the Value of Advanced Treatments in Oncology
Panos Stafylas, Scientific Director, HealThink
Access to innovation in Oncology: From R&D to clinical practice 
Zefi Vlachopioti, Country Market Access Lead, Bristol-Myers Squibb
The Value of Innovation in Oncology
Andonis Karokis, External Affairs Director, MSD Greece
Advancing Personalised Approaches in Oncology in Greece
Socrates Koulouris, Chief Medical Value Officer, Roche
In the era of precision medicine, biomarkers play a key role for patients’ access to innovation
Christos Antonopoulos, MD, PhD, EMBA, Director Oncology Business Unit, AstraZeneca
14:15 – 15:00 Expo – Networking Break

15:00 – 16.15

SESSION 3 | THE FUTURE OF CANCER DIAGNOSIS AND TREATMENT

Moderator: Helena Linardou, MD PhD, PhD Imperial College London, Medical Oncologist, Director- 4th Oncology Dept. & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Founding Board Member W4O-Hellas
Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
Petros Christopoulos, Assistant Professor of Medical Oncology,
Heidelberg University
Treatment of tumors associated with VHL disease
Othon Iliopoulos, Associate Professor of Medicine, Harvard Medical School, Center for Cancer Research, Massachusetts General Hospital
The Introduction of the PRS (Polygenic Risk Score) in Cancer Prevention
Asimina Ηiona, MSc, PhD Doctor of Biochemistry / Molecular Biology, Business Development Manager, Center for Preventive Medicine & Longevity, BIOIATRIKI HEALTHCARE Group
16:15 Closing Remarks
Χορηγίες – Συμμετοχές
Χρυσούλα Κορδούλη, Τ: +30 210 6617 777 (ext. 204), fax: +30 210 6617 778, E: [email protected]
Νίκος Τσάκωνας, M: +30 6936123475 , E: [email protected]
 
Χορηγίες – Συμμετοχές για Κύπρο
Συμμετοχές: Έλενα Χατζηνικολάου, T. (+357)  96494925, [email protected]
Χορηγίες: Γιώργος Λοϊζου, T.  (+357) 99 103323, E. [email protected]
 
Πληροφορίες
Ναταλία Τουμπανάκη, Τ: +30 210 6617 777 (ext. 289), F: 210 6617778, E: [email protected]
Νέλλη Καψή, Τ: 210 6617777 (εσωτ. 204), F: 210 6617778, E: [email protected]

BOUSSIAS

 Κλεισθένους 338, 15344, Γέρακας, Αττική, Ελλάδα
  +30 210 6617777
  +30 210 6617778
  www.boussias.com